Chronic Obstructive Pulmonary Disease (COPD)DIGILIB-RRNCT07687836
Retrospective Evaluation of the Implementation of a Digital Solution Supporting the Delivery of Pulmonary Rehabilitation Programs in Private Physiotherapy Practice
An observational study of Chronic Obstructive Pulmonary Disease (COPD) and Respiration Disorders, run by ADIR Association at 1 site in France.
Trial summary
Pulmonary rehabilitation improves exercise capacity, functional status, symptoms and quality of life in individuals with chronic respiratory diseases. However, access to pulmonary rehabilitation remains limited due to insufficient availability of specialized centers and geographical, organizational, logistical, and… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Chronic Obstructive Pulmonary Disease (COPD), Respiration Disorders, Pulmonary Rehabilitation
- What is being tested?
- TELEREHAPP-supported pulmonary rehabilitation
- Type of treatment
- Medical device
- How many people
- 50 participants
- Where
- 1 siteFrance
- Study dates
- 1 Sep 2025to 1 Jun 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients with chronic respiratory diseases.
Who may be able to join
- Age superior to 18 years;
- Referred for pulmonary rehabilitation in private physiotherapy practice.
- Non-inclusion Criteria:
- Not applicable
Who cannot join
- Not applicable
Trial locations and contacts
1 site in 1 country.
About this study
Pulmonary rehabilitation improves exercise capacity, functional status, symptoms and quality of life in individuals with chronic respiratory diseases. However, access to pulmonary rehabilitation remains limited due to insufficient availability of specialized centers and geographical, organizational, logistical, and financial barriers. Delivering pulmonary rehabilitation in private physiotherapy practices may improve access to care, but implementation can be challenged by limited resources, equipment, and support tools.
A field-based implementation program was conducted from summer 2025 to support physiotherapists in delivering pulmonary rehabilitation in private practice through the provision of a digital support solution (TELEREHAPP) and, where appropriate, associated equipment. During this program, physiotherapists collected data on solution use, patient characteristics, and available clinical follow-up indicators. Satisfaction and perceived usability were assessed among both physiotherapists and patients.
This retrospective study aims to analyze the data already collected during the implementation program to evaluate the feasibility of implementation, use, and acceptability of the TELEREHAPP digital solution in private physiotherapy practice, and to describe changes in available clinical outcomes among participating patients.
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD), Respiration Disorders, Pulmonary Rehabilitation, Chronic Respiratory Diseases
- Being tested
- TELEREHAPP-supported pulmonary rehabilitation
- Keywords
- Chronic Obstructive Pulmonary Disease, Pulmonary rehabilitation, Telerehabilitation, Digital Health Technologies, Private Practice Physiotherapy, Chronic respiratory diseases
- Medical subject headings
- Pulmonary Disease, Chronic Obstructive, Respiration Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TELEREHAPP-supported pulmonary rehabilitationDevice
Pulmonary rehabilitation supported by TELEREHAPP consisted of a program delivered in private physiotherapy practice using a digital health application designed to support the implementation, monitoring, and follow-up of rehabilitation and physical activity programs. Depending on the physiotherapist's usual practice and the patient's needs, the program could include endurance exercise training, muscle strengthening, physical activity coaching, self-administered questionnaires, and individualized monitoring by the physiotherapist. The digital solution was used as a support tool for care delivery and follow-up; the content, duration, frequency, and modalities of the program were determined by the treating physiotherapist.
| Study group | Role | What they receive |
|---|---|---|
| Participants | Physiotherapists and patients with chronic respiratory diseases participating in a pulmonary rehabilitation program in a private physiotherapy practice using a digital solution (TELEREHAPP). Receives: Device: TELEREHAPP-supported pulmonary rehabilitation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Physiotherapist Adoption of the Digital Solution
Proportion of equipped physiotherapists who used the solution to support at least one patient during the experimentation period.
Measured: 6 to 10 months
Secondary outcomes (17)
Physiotherapist Acceptance Rate
Proportion of contacted physiotherapists who agreed to be equipped with the digital solution.
Measured: Baseline
Number of Patients Managed
Total number of patients managed, number per physiotherapist, and number per physiotherapist per month.
Measured: 6 to 10 months
Modules Used
Types of modules used within the digital solution (endurance training, muscle strengthening, physical activity coaching, self-administered questionnaires).
Measured: 6 to 10 months
Number of Sessions Completed
Number of sessions completed for each module.
Measured: 6 to 10 months
Program Duration
Duration of the proposed programs.
Measured: 6 to 10 months
Program Frequency
Frequency of the proposed programs.
Measured: 6 to 10 months
Physiotherapist Satisfaction
Satisfaction of physiotherapists with the care pathway involving the digital solution, assessed using an adapted Client Satisfaction Questionnaire-8 items. Scores therefore range from 8 to 32, with higher values indicating higher satisfaction.
Measured: 6 to 10 months
Patient Satisfaction
Satisfaction of patients with the care pathway involving the digital solution, assessed using the Client Satisfaction Questionnaire-8 items. Scores therefore range from 8 to 32, with higher values indicating higher satisfaction.
Measured: 6 to 10 months
Perceived Usability - Physiotherapists
Perceived usability of the digital solution by physiotherapists, assessed using the System Usability Scale. Scores therefore range from 0 to 100, with higher values indicating higher satisfaction.
Measured: 6 to 10 months
Perceived Usability - Patients
Perceived usability of the digital solution by patients, assessed using the System Usability Scale. Scores therefore range from 0 to 100, with higher values indicating higher satisfaction.
Measured: 6 to 10 months
Exercise Capacity - 6-Minute Walk Distance
Exercise capacity will be assessed using the 6-Minute Walk Test (6MWT) before and after the rehabilitation program. The test measures the distance walked in 6 minutes, expressed in meters, with higher values indicating greater exercise capacity.
Measured: 8 to 10 weeks
Exercise Capacity - 6-Minute Stepper Test (6MST)
Exercise capacity will be assessed using the 6-Minute Stepper Test (6MST) before and after the rehabilitation program. The outcome is the number of steps completed during the test over 6 minutes. Higher values indicate better exercise capacity.
Measured: 8 to 10 weeks
Exercise Capacity - 1-Minute Sit-to-Stand Test (1STS)
Exercise capacity will be assessed using the 1-Minute Sit-to-Stand Test (1STS) before and after the rehabilitation program. The test measures the number of sit-to-stand repetitions completed in 1 minute, with higher values indicating greater exercise capacity.
Measured: 8 to 10 weeks
Health Status
Health status will be assessed using the Chronic obstructive pulmonary disease Assessment Test (CAT) before and after the rehabilitation program and after 1 year of the enrollement date. The score ranges from 0 to 40, with higher values indicating greater impairment of health status. The established minimal clinically important difference for this questionnaire is -2.5 points.
Measured: 8 to 10 weeks
Respiratory Quality of Life
Assessed using the Visual Simplified Respiratory Questionnaire (VSRQ). The score ranges from 0 to 80, with higher values indicating greater quality of life. The established minimal clinically important difference for this questionnaire is 3.4 points.
Measured: 8 to 10 weeks
Psychological Status - Anxiety
Symptoms of anxiety will be assessed using the Hospital Anxiety and Depression questionnaire, anxiety subscore, before and after the rehabilitation program and after 1 year of the enrollement date. The score ranges from 0 (best) to 21 (worst). The pre-specified minimal clinically important difference is set at -1.5 point.
Measured: 8 to 10 weeks
Psychological Status - Depression
Symptoms of anxiety will be assessed using the Hospital Anxiety and Depression questionnaire, anxiety subscore, before and after the rehabilitation program and after 1 year of the enrollement date. The score ranges from 0 (best) to 21 (worst). The pre-specified minimal clinically important difference is set at -1.5 point.
Measured: 8 to 10 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jul 2026
- Study start1 Sep 2025
- Primary completion1 Jun 2026
- Study completion1 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Obstructive Pulmonary Disease (COPD)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- ADIR Association
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Tristan Bonnevie, Principal investigator, ADIR Association
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07687836
- Sponsor's protocol ID
- DIGILIB-RR
- Acronym
- DIGILIB-RR
- Status last verified
- May 2026
- First submitted
- 22 Jun 2026
- Last updated
- 7 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Data will be made available upon reasonable request for research purposes after publication. This includes de-identified data related to demographic characteristics, as well as endpoints published either in the main manuscript or any supplemental data. Requests should be sent to t.bonnevie@adir-hautenormandie.com
Study at a glance
From the registry record, last updated by the sponsor on 7 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Retrospective Evaluation of the Implementation of a Digital Solution Supporting the Delivery of Pulmonary Rehabilitation Programs in Private Physiotherapy Practice
- ClinicalTrials.gov ID
- NCT07687836
- Acronym / sponsor ID
- DIGILIB-RR / DIGILIB-RR
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD), Respiration Disorders, Pulmonary Rehabilitation, Chronic Respiratory Diseases
- Keywords
- Chronic Obstructive Pulmonary Disease, Pulmonary rehabilitation, Telerehabilitation, Digital Health Technologies, Private Practice Physiotherapy, Chronic respiratory diseases
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- ADIR AssociationUniversity, hospital or other
- Study start
- 1 Sep 2025 (actual)
- Primary completion
- 1 Jun 2026 (actual)
- Study completion
- 1 Jun 2027 (estimated)
- First posted
- 7 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pulmonary rehabilitation improves exercise capacity, functional status, symptoms and quality of life in individuals with chronic respiratory diseases. However, access to pulmonary rehabilitation remains limited due to insufficient availability of specialized centers and geographical, organizational, logistical, and financial barriers. Delivering pulmonary rehabilitation in private physiotherapy practices may improve access to care, but implementation can be challenged by limited resources, equipment, and support tools.
A field-based implementation program was conducted from summer 2025 to support physiotherapists in delivering pulmonary rehabilitation in private practice through the provision of a digital support solution (TELEREHAPP) and, where appropriate, associated equipment. During this program, physiotherapists collected data on solution use, patient characteristics, and available clinical follow-up indicators. Satisfaction and perceived usability were assessed among both physiotherapists and patients.
This retrospective study aims to analyze the data already collected during the implementation program to evaluate the feasibility of implementation, use, and acceptability of the TELEREHAPP digital solution in private physiotherapy practice, and to describe changes in available clinical outcomes among participating patients.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Participants | – | Device: TELEREHAPP-supported pulmonary rehabilitationPhysiotherapists and patients with chronic respiratory diseases participating in a pulmonary rehabilitation program in a private physiotherapy practice using a digital solution (TELEREHAPP). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients with chronic respiratory diseases.
Key inclusion criteria (4 listed)
- Age superior to 18 years;
- Referred for pulmonary rehabilitation in private physiotherapy practice.
- Not applicable
Key exclusion criteria (1 listed)
- Not applicable
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TELEREHAPP-supported pulmonary rehabilitationPulmonary rehabilitation supported by TELEREHAPP consisted of a program delivered in private physiotherapy practice using a digital health application designed to support the implementation, monitoring, and follow-up of rehabilitation and physical activity programs. Depending on the physiotherapist's usual practice and the patient's needs, the program could include endurance exercise training, muscle strengthening, physical activity coaching, self-administered questionnaires, and individualized monitoring by the physiotherapist. The digital solution was used as a support tool for care delivery and follow-up; the content, duration, frequency, and modalities of the program were determined by the treating physiotherapist. | Device | Participants |
Primary outcome
Physiotherapist Adoption of the Digital Solution
Time frame: 6 to 10 months
Proportion of equipped physiotherapists who used the solution to support at least one patient during the experimentation period.
17 secondary outcomes
Physiotherapist Acceptance Rate
Time frame: Baseline
Number of Patients Managed
Time frame: 6 to 10 months
Modules Used
Time frame: 6 to 10 months
Number of Sessions Completed
Time frame: 6 to 10 months
Program Duration
Time frame: 6 to 10 months
Program Frequency
Time frame: 6 to 10 months
Physiotherapist Satisfaction
Time frame: 6 to 10 months
Patient Satisfaction
Time frame: 6 to 10 months
Perceived Usability - Physiotherapists
Time frame: 6 to 10 months
Perceived Usability - Patients
Time frame: 6 to 10 months
Exercise Capacity - 6-Minute Walk Distance
Time frame: 8 to 10 weeks
Exercise Capacity - 6-Minute Stepper Test (6MST)
Time frame: 8 to 10 weeks
Exercise Capacity - 1-Minute Sit-to-Stand Test (1STS)
Time frame: 8 to 10 weeks
Health Status
Time frame: 8 to 10 weeks
Respiratory Quality of Life
Time frame: 8 to 10 weeks
Psychological Status - Anxiety
Time frame: 8 to 10 weeks
Psychological Status - Depression
Time frame: 8 to 10 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jul 2026.
- Individual participant dataSharing planned: Yes. Data will be made available upon reasonable request for research purposes after publication. This includes de-identified data related to demographic characteristics, as well as endpoints published either in the main manuscript or any supplemental data. Requests should be sent to t.bonnevie@adir-hautenormandie.com
Related trials for Chronic Obstructive Pulmonary Disease (COPD)
Recruiting
Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada
Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
Not yet recruitingPhase 2
Phase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients
COPD, Chronic Obstructive Pulmonary Disease (COPD)
Not yet recruitingPhase 3
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
Chronic Obstructive Pulmonary Disease
RecruitingObservational study
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Chronic Obstructive Pulmonary Disease (COPD), Smoking
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Tristan Bonnevie principal investigator
ADIR Association
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Obstructive Pulmonary Disease (COPD) and Respiration Disorders, run by ADIR Association at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Physiotherapist Adoption of the Digital Solution (time frame: 6 to 10 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.